Keys And Regulators Of Nanoscale Theranostics 

¹Biosensors and Bioelectronics Centre, IFM, Linkoping University, Linkoping 583 81, Sweden

²Institute of Experimental Physics, Otto-von-Güericke University Magdeburg, Germany

³Plasma & Coatings Physics Division, IFM-Materials, Physics, Linköping University, SE-581 83 Linköping, Sweden

⁴Department of Chemistry, IFM, Linkoping University, Linkoping 583 81, Sweden

⁵Department of Science and Technology, Campus Norrköping, Linköping University, Norrköping 60174, Sweden

⁶Molecular Physics, IFM, Linköping University, Linköping 583 81, Sweden

⁷Tekidag AB, Linkoping 58431, Sweden

^§Authors contributed equally.

Adv. Mater. Lett., 2015, 6 (2), pp 87-98

DOI: 10.5185/amlett.2015.1045

Publication Date (Web): Feb 08, 2015

Copyright © IAAM-VBRI Press

E-mail: ashutosh.tiwari@liu.se

Abstract

Nanoscale theragnosis is the biomedical aspect of nanomaterials for simultaneous diagnosis and therapy. The last decade was completely devoted by the scientist to combine the advancement in nanotechnology molecular biotechnology for the development of future nanomedicine. The approach started with the development of target-specific delivery of the cargo imaging molecule or drugs for biomedical applications. The cutting edge advantages of the nanoscale materials (e.g., large surface to volume ratio, size-shape dependent physicochemical properties and multi-functionality etc.) proved themselves as the most potential preferences to design optimal therapy for the personalized medicine. The present tutorial review will highlight the recent advances in the development on the regulation of such theragnosis system and their biomedical perspectives to act as a future nanomedicine.

Keywords

Nanomedicine, theranostics, therapy, personalized medicine.